Balance Sheet Data

Alnylam Pharmaceuticals, Inc. (ALNY)

$237.715

+6.38 (+2.76%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 1,690.621,084.161,536.161,874.392,435.5615,307.3629,553.0557,056.42110,155.60212,671.20
Total Cash (%)
Account Receivables 3418.7643.01102.41198.57413.15797.651,539.982,973.155,740.10
Account Receivables (%)
Inventories -24.0756.3575.2086.36339.29655.041,264.652,441.594,713.84
Inventories (%)
Accounts Payable 28.3559.7149.8851.9773.43499.39964.151,861.423,593.756,938.24
Accounts Payable (%)
Capital Expenditure -104.21-126.89-140.16-70.36-76.37-1,214.02-2,343.83-4,525.10-8,736.36-16,866.79
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.